Literature DB >> 16615687

A statistical analysis of factors predisposing patients to heparin resistance.

Tanee Chan1, Nian Chih Hwang, Chong Hee Lim.   

Abstract

Heparin resistance (HR) is occasionally encountered in cardiac surgery. The objective of this study is to identify possible factors predisposing patients to heparin resistance. Four hundred patients scheduled for elective cardiac surgery requiring the use of cardiopulmonary bypass (CPB) were enrolled in this study. Data collection included: demographic data, types of preoperative anticoagulant/antiplatelet therapy, preoperative haematological and biochemical laboratory results, medical condition, baseline activated clotting time (ACT) and infusion volume prior to heparinisation. Patients who require 5 mg/kg or more to achieve ACT greater than 400 seconds before CPB were considered to be heparin resistant. All data was tested with a preliminary univariate analysis and factors associated with HR (p value <0.05) were entered into a multivariate logistic regression analysis. Factors associated with HR with a p value <0.05 are considered predictors for HR. Thirty-two (8.0%) of the 400 patients fulfilled the criteria for HR. Preoperative heparin (p =0.025), low molecular weight heparin (p =0.049), plateletcount > or = 300,000/ml (p =0.022) and albumin plasma concentration < or = 35 g/dl 0, =0.044) are significantly associated with HR. HR patients also tend to require more volume replacement prior to CPB to maintain haemodynamic stability p=0.007).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16615687     DOI: 10.1191/0267659106pf855oa

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  6 in total

1.  Heparin responsiveness during off-pump coronary artery bypass graft surgery: predictors and clinical implications.

Authors:  Duk-hee Chun; Seong-wan Baik; So Yeon Kim; Jae Kwang Shim; Jong Chan Kim; Young Lan Kwak
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

2.  The Impact of Antithrombin III Use in Achieving Anticoagulant Goals in Pediatric Patients.

Authors:  Allison J Jones; Keliana L O'Mara; Brian J Kelly; Ravi S Samraj
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Sep-Oct

3.  Stabilized infective endocarditis and altered heparin responsiveness during cardiopulmonary bypass.

Authors:  Sungwon Na; Jae Kwang Shim; Duk-Hee Chun; Dae Hee Kim; Seong Wook Hong; Young-Lan Kwak
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

4.  Evidence-based algorithm for heparin dosing before cardiopulmonary bypass. Part 1: Development of the algorithm.

Authors:  Mark C McKinney; Jeffrey B Riley
Journal:  J Extra Corpor Technol       Date:  2007-12

5.  The influence of heparin resistance on postoperative complications in patients undergoing coronary surgery.

Authors:  Piotr Knapik; Daniel Cieśla; Roman Przybylski; Tomasz Knapik
Journal:  Med Sci Monit       Date:  2012-02

6.  Preoperative Low-Molecular-Weight Heparin Prophylaxis Associated with Increased Heparin Resistance Frequency in On-Pump Coronary Artery Bypass Graft Surgery.

Authors:  Onur Saydam; Mehmet Atay; Deniz Serefli; Suat Doganci; Ulas Kumabasar; Mustafa Yılmaz; Rıza Dogan; Metin Demircin
Journal:  Cardiol Res Pract       Date:  2019-04-16       Impact factor: 1.866

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.